Literature DB >> 6983846

Legionnaires' pneumonia after aerosol exposure in guinea pigs and rats.

G S Davis, W C Winn, D W Gump, J E Craighead, H N Beaty.   

Abstract

We developed an animal model of Legionnaires' pneumonia to permit study of aerosol infection, pathogenesis, and pulmonary host defense mechanisms in this disease. Guinea pigs and rats were exposed in a nose-only inhalation facility for 30 min to an aerosol of Burlington serogroup 1 Legionella pneumophila. Lungs contained 10(3) to 10(4) L. pneumophila immediately after exposure. Both guinea pigs and rats developed pneumonia, with 100% infectivity by microbiologic, histologic, and serologic criteria. Guinea pigs demonstrated illness, fever, and 56% mortality; rats showed little illness and 11% mortality. In both species, diffuse patchy pneumonitis coalesced and consolidated as the disease progressed. Aerosol challenge with 3H-L. pneumophila showed exponential growth of the bacteria in the lungs of both species. Guinea pigs and rats can be infected by aerosol exposure to L. pneumophila to produce a disease that closely simulates human Legionnaires' pneumonia. Rapid initial intrapulmonary growth suggests that resident lung defense mechanisms are quite ineffective against L. pneumophila, and that recruited or immunospecific defenses may be more critical in the outcome of infection. The difference in severity of illness between guinea pigs and rats may be exploited for different experimental designs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983846     DOI: 10.1164/arrd.1982.126.6.1050

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

1.  Coinoculation with Hartmannella vermiformis enhances replicative Legionella pneumophila lung infection in a murine model of Legionnaires' disease.

Authors:  J Brieland; M McClain; L Heath; C Chrisp; G Huffnagle; M LeGendre; M Hurley; J Fantone; C Engleberg
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  Virulence factors of the family Legionellaceae.

Authors:  J N Dowling; A K Saha; R H Glew
Journal:  Microbiol Rev       Date:  1992-03

Review 3.  Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses.

Authors:  P Andersen
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

Review 4.  Photochemical air pollution. Part II.

Authors:  E Goldstein; D Dungworth; P F Ricci
Journal:  West J Med       Date:  1985-04

5.  Intrapulmonary Hartmannella vermiformis: a potential niche for Legionella pneumophila replication in a murine model of legionellosis.

Authors:  J Brieland; M McClain; M LeGendre; C Engleberg
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Gentamicin-Containing Peptone-Yeast Extract Medium for Cocultivation of Hartmannella vermiformis ATCC 50256 and Virulent Strains of Legionella pneumophila.

Authors:  R M Wadowsky; L Wang; S Laus; J N Dowling; J M Kuchta; S J States; R B Yee
Journal:  Appl Environ Microbiol       Date:  1995-12       Impact factor: 4.792

7.  Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease.

Authors:  J Brieland; P Freeman; R Kunkel; C Chrisp; M Hurley; J Fantone; C Engleberg
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge.

Authors:  S J Blander; R F Breiman; M A Horwitz
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Ten Questions Concerning the Aerosolization and Transmission of Legionella in the Built Environment.

Authors:  Aaron J Prussin; David Otto Schwake; Linsey C Marr
Journal:  Build Environ       Date:  2017-06-13       Impact factor: 6.456

Review 10.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.